Potassium Phosphates Injection, Solution
NDC Package 65219-656-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Potassium Phosphates injection is potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated. This formulation utilizes a injection, solution delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 65219-656 and is authorized under FDA application NDA212832.

Identification & Billing

NDC Package Code
65219-656-10
Package Description
24 POUCH in 1 CARTON / 1 BAG in 1 POUCH (65219-656-01) / 100 mL in 1 BAG
Product Code
65219-656
11-Digit Billing Format
65219065610
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 2688947 - potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection
  • RxCUI: 2688947 - 250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - 250 ML dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - 250 ML dibasic Pot phosphate 4.72 MG/ML / monobasic Pot phosphate 4.48 MG/ML Injection
  • RxCUI: 2688947 - phosphorus 15 MMOL / potassium 22 MEQ per 250 ML Injection

Clinical Specifications

Proprietary Name
Potassium Phosphates
Non-Proprietary Name
Potassium Phosphates
Substance Name
Dibasic Potassium Phosphate; Monobasic Potassium Phosphate
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated.

Regulatory & Marketing

Labeler Name
Fresenius Kabi Usa, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA212832
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65219-656-10 identifies a specific commercial package of 24 pouch in 1 carton / 1 bag in 1 pouch (65219-656-01) / 100 ml in 1 bag of Potassium Phosphates, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This injection, solution is formulated for intravenous use and contains dibasic potassium phosphate; monobasic potassium phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on June 15, 2025. The current certification is valid through December 31, 2026.

How is this Fresenius Kabi Usa, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65219065610. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65219-656-10
11-Digit CMS (5-4-2)
65219-0656-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.